Tag - CEACAM1

miR-449a disturbs atherosclerotic plaque stability in streptozotocin and high-fat diet-induced diabetic mice by targeting CEACAM1 | Diabetology & Metabolic Syndrome

May 9, 2024

Animals All animal experiments in this study were approved by the Ethics Committee of Yunnan Labreal Biotech Ltd. Co., and operations followed the standard...